Effect of cystic fibrosis-associated mutations in the fourth intracellular loop of cystic fibrosis transmembrane conductance regulator

被引:74
作者
Cotten, JF
Ostedgaard, LS
Carson, MR
Welsh, MJ
机构
[1] UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,IOWA CITY,IA 52242
[2] UNIV IOWA,COLL MED,DEPT INTERNAL MED,IOWA CITY,IA 52242
[3] UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242
关键词
D O I
10.1074/jbc.271.35.21279
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cystic fibrosis transmembrane conductance regulator (CFTR) contains multiple membrane spanning sequences that form a Cl- channel pore and cytosolic domains that control the opening and closing of the channel. The fourth intracellular loop (ICL4), which connects the tenth and eleventh transmembrane spans, has a primary sequence that is highly conserved across species, is the site of a preserved sequence motif in the ABC transporter family, and contains a relatively large number of missense mutations associated with cystic fibrosis (CF). To investigate the role of ICL4 in CFTR function and to learn how CF mutations in this region disrupt function, we studied several CF-associated ICL4 mutants. We found that most ICL4 mutants disrupted the biosynthetic processing of CFTR, although not as severely as the most common Delta F508 mutation. The mutations had no discernible effect on the channel's pore properties; but some altered gating behavior, the response to increasing concentrations of ATP, and stimulation in response to pyrophosphate. These effects on activity were similar to those observed with mutations in the nucleotide-binding domains, suggesting that ICL4 might help couple activity of the nucleotide-binding domains to gating of the Cl- channel pore. The data also explain how these mutations cause a loss of CFTR function and suggest that some patients with mutations in ICL4 may have a milder clinical phenotype because they retain partial activity of CFTR at the cell membrane.
引用
收藏
页码:21279 / 21284
页数:6
相关论文
共 46 条
[1]   REGULATION BY ATP AND ADP OF CFTR CHLORIDE CHANNELS THAT CONTAIN MUTANT NUCLEOTIDE-BINDING DOMAINS [J].
ANDERSON, MP ;
WELSH, MJ .
SCIENCE, 1992, 257 (5077) :1701-1704
[2]   DEMONSTRATION THAT CFTR IS A CHLORIDE CHANNEL BY ALTERATION OF ITS ANION SELECTIVITY [J].
ANDERSON, MP ;
GREGORY, RJ ;
THOMPSON, S ;
SOUZA, DW ;
PAUL, S ;
MULLIGAN, RC ;
SMITH, AE ;
WELSH, MJ .
SCIENCE, 1991, 253 (5016) :202-205
[3]   IDENTIFICATION OF 4 NEW MUTATIONS IN THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE - I148T, L1077P, Y1092X, 2183AA-]G [J].
BOZON, D ;
ZIELENSKI, J ;
RININSLAND, F ;
TSUI, LC .
HUMAN MUTATION, 1994, 3 (03) :330-332
[4]   PYROPHOSPHATE STIMULATES WILD-TYPE AND MUTANT CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CL- CHANNELS [J].
CARSON, MR ;
WINTER, MC ;
TRAVIS, SM ;
WELSH, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (35) :20466-20472
[5]   5'-ADENYLYLIMIDODIPHOSPHATE DOES NOT ACTIVATE CFTR CHLORIDE CHANNELS IN CELL-FREE PATCHES OF MEMBRANE [J].
CARSON, MR ;
WELSH, MJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01) :L27-L32
[6]   THE 2 NUCLEOTIDE-BINDING DOMAINS OF CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) HAVE DISTINCT FUNCTIONS IN CONTROLLING CHANNEL ACTIVITY [J].
CARSON, MR ;
TRAVIS, SM ;
WELSH, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (04) :1711-1717
[7]   Structural and functional similarities between the nucleotide-binding domains of CFTR and GTP-binding proteins [J].
Carson, MR ;
Welsh, MJ .
BIOPHYSICAL JOURNAL, 1995, 69 (06) :2443-2448
[8]   A CHANGE IN GATING MODE LEADING TO INCREASED INTRINSIC CL- CHANNEL ACTIVITY COMPENSATES FOR DEFECTIVE PROCESSING IN A CYSTIC-FIBROSIS MUTANT CORRESPONDING TO A MILD FORM OF THE DISEASE [J].
CHAMPIGNY, G ;
IMLER, JL ;
PUCHELLE, E ;
DALEMANS, W ;
GRIBKOFF, V ;
HINNRASKY, J ;
DOTT, K ;
BARBRY, P ;
PAVIRANI, A ;
LAZDUNSKI, M .
EMBO JOURNAL, 1995, 14 (11) :2417-2423
[9]  
CHANG XB, 1994, J BIOL CHEM, V269, P18572
[10]   DEFECTIVE INTRACELLULAR-TRANSPORT AND PROCESSING OF CFTR IS THE MOLECULAR-BASIS OF MOST CYSTIC-FIBROSIS [J].
CHENG, SH ;
GREGORY, RJ ;
MARSHALL, J ;
PAUL, S ;
SOUZA, DW ;
WHITE, GA ;
ORIORDAN, CR ;
SMITH, AE .
CELL, 1990, 63 (04) :827-834